CARL MUSCHENHEIM, F.A.C.P.; WALSH MCDERMOTT; SUSAN J. HADLEY; HARRIET HULL-SMITH; ALICE TRACY
This content is PDF only. Please click on the PDF icon to access.
In a preceding paper,1 observations on the streptomycin treatment of meningeal and generalized hematogenous tuberculosis were presented. On the basis of these studies and in confirmation of the previous reports of Hinshaw and Feldman,2, 3 it was concluded that streptomycin is capable of exerting a powerful effect upon the course of tuberculous infections in humans. It was further concluded1 that in miliary tuberculosis, at least, the development of streptomycin-resistance as detected in vitro, reflects the presence of a drug-resistant infection in vivo.
The present report is concerned with the results observed in 43 patients with pulmonary tuberculosis who received
MUSCHENHEIM C, MCDERMOTT W, HADLEY SJ, et al. STREPTOMYCIN IN THE TREATMENT OF TUBERCULOSIS IN HUMANS: II. PULMONARY TUBERCULOSIS*. Ann Intern Med. 1947;27:989–1027. doi: https://doi.org/10.7326/0003-4819-27-6-989
Download citation file:
Published: Ann Intern Med. 1947;27(6):989-1027.
Infectious Disease, Mycobacterial Infections, Pulmonary Tuberculosis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use